Characterization of glycan isomers by trapped ion mobility spectrometry-electron activated dissociation tandem mass spectrometry
Project Number5R21GM122635-02
Former Number1R21CA207703-01
Contact PI/Project LeaderLIN, CHENG
Awardee OrganizationBOSTON UNIVERSITY MEDICAL CAMPUS
Description
Abstract Text
Project summary/abstract
Glycosylation plays vital roles in many cellular events, including protein folding, pathogen recognition, and
cancer metastasis. The structural complexity and diversity of glycans parallel their diverse functions. Whereas
the primary structures of linear biopolymers, such as proteins and oligonucleotides, are uniquely defined by
their one-dimensional sequence, full structural characterization of a glycan requires determination of its two-
dimensional topology, linkage and stereochemical configurations. Further analytical challenges arise from the
non-template-driven nature of glycan biosynthesis, resulting in glycomes comprising a repertoire of closely-
related structures, many of which structural isomers.
Recently, a number of electron activated dissociation (ExD) methods have been developed in mass
spectrometry laboratories for glycan analysis. Electron capture dissociation (ECD), electron transfer
dissociation (ETD), and electronic excitation dissociation (EED) can yield rich structurally informative fragment
ions for glycans analyzed in the positive ionization mode. In the negative ionization mode, electron detachment
dissociation (EDD) and negative ETD (NETD) are powerful fragmentation methods for sequencing of acidic
glycosaminoglycans. Meanwhile, ion mobility spectrometry (IMS) has been applied to separation of glycans. As
a post-ionization, gas-phase separation method, IMS complements solution-phase separation methods such
as capillary electrophoresis (CE) and liquid chromatography (LC), and can achieve isomer resolution based on
differences in their gas-phase conformations. However, conventional drift-time IMS separation occurs on too
short a time-scale to be compatible with the slower ExD analysis methods. A new IMS technique, termed
trapped ion mobility spectrometry (TIMS), was recently introduced by Bruker Daltonics. We have demonstrated
successful coupling of TIMS to high-performance Fourier-transform ion cyclotron resonance (FTICR) MS
instrument for separation and identification of glycan linkage isomers. Here, we propose to modify the TIMS
device and its control software, for improved mobility resolution, increased m/z operating range, and better
integration with ExD-FTICR MS/MS analysis. We will then utilize the improved TIMS-ExD method for detailed
structural characterization of glycans. We will also use TIMS-ExD MS/MS in conjunction with off-line LC
fractionation to produce a library that contains identified glycan structures with their collision cross section
values. This library will be made available to public.
The initial development will be carried out on the FTICR MS platform, as it offers superior mass accuracy and
resolving power, as well as the best ExD performance. The technology we develop here can later be
transferred to other, more affordable MS instruments, following the development of alternative ECD cells to
bring the ExD capability to non-ICR instruments.
Public Health Relevance Statement
Project narrative
Structural characterization of glycans requires sensitive analytical methods that can separate and identify each
component in a complex mixture. We propose to develop an analytical approach that couples TIMS to FTICR
MS for generating IMS-ExD tandem mass spectra with high mobility and mass resolutions, and rich structural
information for detailed structural characterization of glycans, including isomers. The identified structures with
their CCS values will be deposited into a public database.
No Sub Projects information available for 5R21GM122635-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R21GM122635-02
Patents
No Patents information available for 5R21GM122635-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R21GM122635-02
Clinical Studies
No Clinical Studies information available for 5R21GM122635-02
News and More
Related News Releases
No news release information available for 5R21GM122635-02
History
No Historical information available for 5R21GM122635-02
Similar Projects
No Similar Projects information available for 5R21GM122635-02